Tirzepatide Injections For Weight Loss Treatment

Tirzepatide Injections For Weight Loss

As we get older, shedding pounds can become extremely challenging. Fortunately, Tirzepatide is available to offer assistance. Research has shown that Tirzepatide effectively decreases appetite, enhances eating control, and diminishes food cravings, while also improving glycemic control. Complete your initial assessment in minutes using our online intake form.

Embark on Your Weight Loss Transformation

If you’re ready to explore the potential of Tirzepatide injections for weight loss and embark on a journey towards a healthier, more confident you, eMD Men’s Wellness is here to guide you. Our comprehensive approach to weight loss ensures that you receive the support and guidance you need to achieve lasting results. Contact us today to take the first step towards a transformed you with Tirzepatide injections at eMD Men’s Wellness.

How does Tiezpatide work for weight loss

Tirzepatide is an investigational medicine being developed for the treatment of obesity and type 2 diabetes. It belongs to a class of medications known as dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists. These medications work by targeting multiple pathways involved in regulating blood sugar levels and appetite.

Tirzepatide is designed to mimic the effects of two natural hormones, GIP and GLP-1, which are involved in glucose metabolism and satiety (feeling of fullness) regulation. By activating these receptors, tirzepatide has the potential to improve blood sugar control, promote weight loss, and potentially lead to other metabolic benefits.

Clinical trials have shown promising results for tirzepatide injections in terms of weight loss and glycemic control in people with obesity and type 2 diabetes. The medication has demonstrated a significant reduction in body weight and improvements in HbA1c levels (a marker of long-term blood sugar control) compared to placebo and other diabetes treatments.

It’s important to note that tirzepatide is still under investigation and has not yet received regulatory approval for commercial use. As with any medication, there can be potential side effects and considerations. Only a healthcare professional can determine if tirzepatide injections are appropriate for an individual based on their medical history, current health status, and treatment goals

Frequently asked question

Unlike phentermine, Tirzepatide is not a stimulant. While other weight loss medications, like phentermine, have stimulating effects that help curb your appetite, Tirzepatide works in a different way (see above).

Yes, Tirzepatide helps to curb your appetite. In addition to slowing gastric emptying to make you feel full for longer, GLP-1 also plays a critical role in how your appetite is regulated.

Tirzepatide is considered to be safe and effective when used as indicated. But every medication comes with risk of adverse side effects. The most common side effects of using Tirzepatide may include nausea, vomiting, diarrhea, stomach (abdominal) pain, and constipation. That is why we start everyone on a low dosage and titrate slowly.

You should notify your healthcare practitioner if you get changes in vision, low blood sugar (hypoglycemia), kidney problems, pancreatitis, or any serious allergic reactions. Symptoms of low blood sugar include sudden sweating, shaking, fast heartbeat, hunger, blurred vision, dizziness, or tingling hands/feet. Tirzepatide shouldn’t be used if you or your family have a history of certain thyroid cancers such as Medullary thyroid cancer or endocrine neoplasia type 2 .Tirzepatide should not be used in people with a history of pancreatitis. Tirzepatide should be used cautiously for people on other blood sugar lowering medications.

Administer TIRZEPATIDE subcutaneously to the abdomen once a week. It may help to use different injection sites around the navel each week.

All patients start on the lowest dose of Tirzepatide at 2.5mgs injected subcutaneously into belly fat every week. All patients increase by following the titration schedule as tolerated (slower if nauseous), up to a total weekly dose of 15mgs each week.